7-oxo-3-[[2-(4-propan-2-ylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl]-3,9-diazabicyclo[3.3.1]nonane-9-carbaldehyde

C24H27N5O2 — CID 175882035

IUPAC7-oxo-3-[[2-(4-propan-2-ylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl]-3,9-diazabicyclo[3.3.1]nonane-9-carbaldehyde
SMILESCC(C)c1ccc(-c2nc3ncccn3c2CN2CC3CC(=O)CC(C2)N3C=O)cc1
InChIInChI=1S/C24H27N5O2/c1-16(2)17-4-6-18(7-5-17)23-22(28-9-3-8-25-24(28)26-23)14-27-12-19-10-21(31)11-20(13-27)29(19)15-30/h3-9,15-16,19-20H,10-14H2,1-2H3
InChIKeyRONVMYFOWNPHDU-UHFFFAOYSA-N
MW417.51 g/mol
LogP2.89
Rot. Bonds5

About 7-oxo-3-[[2-(4-propan-2-ylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl]-3,9-diazabicyclo[3.3.1]nonane-9-carbaldehyde

7-oxo-3-[[2-(4-propan-2-ylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl]-3,9-diazabicyclo[3.3.1]nonane-9-carbaldehyde (PubChem CID 175882035) has the molecular formula C24H27N5O2 and a molecular weight of 417.51 g/mol. Its IUPAC name is 7-oxo-3-[[2-(4-propan-2-ylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl]-3,9-diazabicyclo[3.3.1]nonane-9-carbaldehyde.

Molecular Properties

Compound Name7-oxo-3-[[2-(4-propan-2-ylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl]-3,9-diazabicyclo[3.3.1]nonane-9-carbaldehyde
PubChem CID175882035
Molecular FormulaC24H27N5O2
Molecular Weight417.51 g/mol
Exact Mass417.22
IUPAC Name7-oxo-3-[[2-(4-propan-2-ylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl]-3,9-diazabicyclo[3.3.1]nonane-9-carbaldehyde
SMILESCC(C)c1ccc(-c2nc3ncccn3c2CN2CC3CC(=O)CC(C2)N3C=O)cc1
InChIInChI=1S/C24H27N5O2/c1-16(2)17-4-6-18(7-5-17)23-22(28-9-3-8-25-24(28)26-23)14-27-12-19-10-21(31)11-20(13-27)29(19)15-30/h3-9,15-16,19-20H,10-14H2,1-2H3
InChIKeyRONVMYFOWNPHDU-UHFFFAOYSA-N
XLogP2.89
TPSA70.81 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds5
Heavy Atoms31
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500417.51
LogP ≤ 52.89
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}

Analyze 7-oxo-3-[[2-(4-propan-2-ylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl]-3,9-diazabicyclo[3.3.1]nonane-9-carbaldehyde with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 7-oxo-3-[[2-(4-propan-2-ylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl]-3,9-diazabicyclo[3.3.1]nonane-9-carbaldehyde?
The IUPAC name of 7-oxo-3-[[2-(4-propan-2-ylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl]-3,9-diazabicyclo[3.3.1]nonane-9-carbaldehyde (CID 175882035) is 7-oxo-3-[[2-(4-propan-2-ylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl]-3,9-diazabicyclo[3.3.1]nonane-9-carbaldehyde.
What is the SMILES notation for 7-oxo-3-[[2-(4-propan-2-ylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl]-3,9-diazabicyclo[3.3.1]nonane-9-carbaldehyde?
The canonical SMILES for 7-oxo-3-[[2-(4-propan-2-ylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl]-3,9-diazabicyclo[3.3.1]nonane-9-carbaldehyde is CC(C)c1ccc(-c2nc3ncccn3c2CN2CC3CC(=O)CC(C2)N3C=O)cc1.
What is the InChIKey of 7-oxo-3-[[2-(4-propan-2-ylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl]-3,9-diazabicyclo[3.3.1]nonane-9-carbaldehyde?
The InChIKey is RONVMYFOWNPHDU-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H27N5O2/c1-16(2)17-4-6-18(7-5-17)23-22(28-9-3-8-25-24(28)26-23)14-27-12-19-10-21(31)11-20(13-27)29(19)15-30/h3-9,15-16,19-20H,10-14H2,1-2H3.
What are the key properties of 7-oxo-3-[[2-(4-propan-2-ylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl]-3,9-diazabicyclo[3.3.1]nonane-9-carbaldehyde?
7-oxo-3-[[2-(4-propan-2-ylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl]-3,9-diazabicyclo[3.3.1]nonane-9-carbaldehyde has a molecular weight of 417.51 g/mol, XLogP of 2.89, 5 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 7-oxo-3-[[2-(4-propan-2-ylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl]-3,9-diazabicyclo[3.3.1]nonane-9-carbaldehyde is sourced from PubChem (CID 175882035), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).